Carole J. Spangler
Corporate Officer/Principal presso Clario Medical Imaging, Inc.
Posizioni attive di Carole J. Spangler
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Clario Medical Imaging, Inc.
 Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Storia della carriera di Carole J. Spangler
Precedenti posizioni note di Carole J. Spangler
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DENDREON CORPORATION | Corporate Officer/Principal | - | - |
Formazione di Carole J. Spangler
| The Johns Hopkins University | Doctorate Degree |
| University of Washington | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Clario Medical Imaging, Inc.
Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Carole J. Spangler
- Esperienza
